Cadila Healthcare Latest News

  1. At the end of the inspection, no observation (483) was issued
    Date:19-01-2018
  2. At the end of the inspection, no observation (483) was issued
    Date:19-01-2018
  3. Cadila Healthcare has informed about Statement of Investor Complaints for the quarter ended on December 31, 2017.

    The above information is a part of company’s filings submitted to BSE....

    Date:12-01-2018
  4. It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad
    Date:01-01-2018
  5. Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Valacyclovir Tablets USP’.

    The above information is a part of company’s filings submitted to BSE....

    Date:30-12-2017
  6. It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad
    Date:30-12-2017
  7. Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Clomipramine Hydrochloride Capsules USP.’

    The above information is a part of company&...

    Date:29-12-2017
  8. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad
    Date:29-12-2017
  9. The drug is used to treat hypertension (high blood pressure) and angina (chest pain)
    Date:21-12-2017
  10. Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Nifedipine Extended-Release Tablets USP’.

    The above information is a part of company&...

    Date:21-12-2017
Return to Top
Connect with us Facebook
Connect with us Facebook
Connect with us Linkedin
Connect with us Pintrest
Connect with us Google Plus
Connect with us You Tube
Connect with us Mobile App
 
 
Request a Call Back
Mobile
Invalid Mobile Number
x
Thanks. We will call you shortly.